Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Chronic Kidney Disease III: Interprofessional Care01:28

Chronic Kidney Disease III: Interprofessional Care

563
Chronic kidney disease (CKD) requires collaborative and comprehensive management. CKD progresses through stages and can lead to end-stage kidney disease (ESKD) if untreated. Interprofessional collaboration and patient education are crucial, enabling patients to manage their health and improve their quality of life.Diagnostic approach for chronic kidney diseaseThe diagnosis of CKD primarily focuses on the glomerular filtration rate (GFR), which assesses kidney function by measuring how well...
563
Chronic Kidney Disease IV: Nursing Management01:18

Chronic Kidney Disease IV: Nursing Management

516
Nursing management is essential for preventing complications, maintaining stability, and improving patients' quality of life in chronic kidney disease (CKD). By using a structured approach, nurses help slow CKD progression and support effective patient care​.1. Comprehensive patient assessmentEffective management begins with nurses reviewing the patient’s medical history, and identifying key risk factors like diabetes, hypertension, and nephrotoxic drug use. Nurses assess signs of...
516
Acute Kidney Injury V: Interprofessional Care01:20

Acute Kidney Injury V: Interprofessional Care

438
Acute Kidney Injury (AKI) requires a collaborative healthcare approach to restore renal function and prevent complications. Essential management strategies involve monitoring fluid and electrolyte balance, adjusting medications, initiating dialysis when necessary, and providing nutritional support.Fluid and Electrolyte ManagementFluid Monitoring: Regularly monitoring body weight, central venous pressure, and urine output helps detect fluid imbalances early. Patient intake and output are...
438
Acute Kidney Injury VI: Nursing Management01:22

Acute Kidney Injury VI: Nursing Management

622
Acute Kidney Injury (AKI) results in an inability to maintain fluid, electrolyte, and acid-base balance. Effective nursing management is critical in improving patient outcomes and includes comprehensive patient assessment and targeted interventions.Comprehensive Patient AssessmentA detailed history collection is essential, focusing on any recent infections, nephrotoxic medication use, or chronic conditions such as hypertension and diabetes that may contribute to AKI. During the physical...
622
Chronic Kidney Disease I: Introduction01:25

Chronic Kidney Disease I: Introduction

928
Chronic Kidney Disease (CKD) arises when the kidneys progressively lose their ability to function, ultimately leading to end-stage renal disease. At this advanced stage, the kidneys can no longer filter waste or maintain essential body functions, requiring renal replacement therapy (RRT) through dialysis or a kidney transplant for survival.Early-stage chronic kidney disease and detection challengesIn CKD's early stages, symptoms often remain absent because healthy nephrons compensate for...
928
Acute Kidney Injury IV: Diagnostic Studies and Prevention01:30

Acute Kidney Injury IV: Diagnostic Studies and Prevention

434
Accurate diagnosis and effective prevention are critical in managing Acute Kidney Injury (AKI), which is linked to high mortality rates ranging from 10% to 80%. Timely recognition of at-risk patients and careful monitoring can significantly reduce the likelihood of kidney damage.Diagnostic Assessments:The diagnostic process starts with a comprehensive medical history to identify prerenal, intrarenal, and postrenal causes.Prerenal causes, such as dehydration, hypotension, or blood loss, should...
434

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

SGLT2 inhibitors and nephrolithiasis risk: a meta-analysis.

Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association·2024
Same author

The CONVINCE randomized trial found positive effects on quality of life for patients with chronic kidney disease treated with hemodiafiltration.

Kidney international·2024
Same author

Proximal tubule hypertrophy and hyperfunction: a novel pathophysiological feature in disease states.

Clinical kidney journal·2024
Same author

Exploring the nexus: The place of kidney diseases within the cardiovascular-kidney-metabolic syndrome spectrum.

European journal of internal medicine·2024
Same author

Metabolically healthy obesity and chronic kidney disease risk: exploring the dynamics.

Panminerva medica·2024
Same author

Treatment strategies of the thromboembolic risk in kidney failure patients with atrial fibrillation.

Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association·2024

Related Experiment Video

Updated: Mar 9, 2026

5/6 Nephrectomy Using Sharp Bipolectomy Via Midline Laparotomy in Rats
05:34

5/6 Nephrectomy Using Sharp Bipolectomy Via Midline Laparotomy in Rats

Published on: April 4, 2025

1.9K

Magnesium-based interventions for normal kidney function and chronic kidney disease.

Ziad A Massy1, Ionut Nistor2, Mugurel Apetrii3

  • 1Division of Nephrology, Ambroise Paré Universty Hospital, University of Paris Ouest - Versailles-Saint-Quentin-en-Yvelines (UVSQ), Boulogne Billancourt/ Paris, and Inserm U-1018, Centre de recherche en épidémiologie et santé des populations (CESP), Equipe 5, Villejuif, France.

Magnesium Research
|December 24, 2016
PubMed
Summary
This summary is machine-generated.

Magnesium (Mg) supplementation did not show benefits for mortality in chronic kidney disease (CKD) patients, despite its essential role in the body. Further research is needed to clarify magnesium

Keywords:
CKDcardiovascularmagnesiummortality

More Related Videos

Digital Home-Monitoring of Patients after Kidney Transplantation: The MACCS Platform
07:13

Digital Home-Monitoring of Patients after Kidney Transplantation: The MACCS Platform

Published on: April 12, 2021

5.3K
5/6th Nephrectomy in Combination with High Salt Diet and Nitric Oxide Synthase Inhibition to Induce Chronic Kidney Disease in the Lewis Rat
08:50

5/6th Nephrectomy in Combination with High Salt Diet and Nitric Oxide Synthase Inhibition to Induce Chronic Kidney Disease in the Lewis Rat

Published on: July 3, 2013

24.5K

Related Experiment Videos

Last Updated: Mar 9, 2026

5/6 Nephrectomy Using Sharp Bipolectomy Via Midline Laparotomy in Rats
05:34

5/6 Nephrectomy Using Sharp Bipolectomy Via Midline Laparotomy in Rats

Published on: April 4, 2025

1.9K
Digital Home-Monitoring of Patients after Kidney Transplantation: The MACCS Platform
07:13

Digital Home-Monitoring of Patients after Kidney Transplantation: The MACCS Platform

Published on: April 12, 2021

5.3K
5/6th Nephrectomy in Combination with High Salt Diet and Nitric Oxide Synthase Inhibition to Induce Chronic Kidney Disease in the Lewis Rat
08:50

5/6th Nephrectomy in Combination with High Salt Diet and Nitric Oxide Synthase Inhibition to Induce Chronic Kidney Disease in the Lewis Rat

Published on: July 3, 2013

24.5K

Area of Science:

  • Nephrology
  • Biochemistry
  • Cardiovascular Medicine

Background:

  • Magnesium (Mg) is a vital cation, acting as a cofactor in over 300 enzymatic reactions.
  • Low Mg levels are linked to increased cardiovascular disease (CVD) risk in the general population.
  • The impact of Mg administration on mortality in chronic kidney disease (CKD) patients remains under-investigated as a primary endpoint.

Purpose of the Study:

  • To systematically review the benefits and harms of magnesium in patients with chronic kidney disease (CKD) stages 1-5 and 5D.
  • To evaluate Mg-based interventions in CKD using randomized controlled trials (RCTs) and quasi-RCTs.

Main Methods:

  • Conducted a systematic literature search for studies on Mg interventions in CKD.
  • Included randomized controlled trials (RCTs) and quasi-RCTs assessing Mg benefits and harms.
  • Focused on Mg's role as a phosphate binder and its effect on circulating Mg levels.

Main Results:

  • Mg salts may reduce intestinal phosphate absorption, potentially offering dual benefits.
  • Existing RCTs on Mg supplementation in CKD patients did not demonstrate a favorable effect on mortality.
  • Evidence for Mg supplementation's positive effect on vascular calcification is very limited.

Conclusions:

  • Despite associations between low Mg and increased mortality in CKD, current RCTs do not support Mg supplementation for reducing mortality.
  • The role of Mg in CKD patients requires deeper investigation.
  • Well-designed research specifically targeting Mg's role in CKD is necessary due to limited evidence.